<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2019-4-5-11</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2290</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARTERIAL HYPERTENSION</subject></subj-group></article-categories><title-group><article-title>Самоконтроль и клиническое измерение  артериального давления в оценке распространенности и маркеров фенотипов артериальной гипертонии в когортном исследовании</article-title><trans-title-group xml:lang="en"><trans-title>Home and clinical office pressure measurements in assessment of the prevalence and markers of arterial hypertension phenotypes in a cohort study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3506-6168</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Платонова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Platonova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Платонова Елена Вячеславовна — кандидат медицинских наук, старший научный сотрудник лаборатории применения амбулаторных диагностических методов в профилактике хронических неинфекционных заболеваний.</p><p>SPIN-код: 8255-2796</p><p>Москва.</p><p>Тел.: +7 (499) 553­69­25</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">Eplatonova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7669-9714</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деев</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Deev</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Деев Александр Дмитриевич — кандидат физико-математических наук,  руководитель лаборатории  биостатистики отдела  эпидемиологии  хронических неинфекционных заболеваний.</p><p>SPIN-код: 2897-1287</p><p>Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">ADeev@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5195-8997</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбунов</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbunov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горбунов Владимир Михайлович — доктор медицинских наук, профессор,   руководитель лаборатории  применения  амбулаторных диагностических методов  в  профилактике  хронических неинфекционных заболеваний.</p><p>SPIN-код: 5111-1303</p><p>Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">Vgorbunov@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2087-6483</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шальнова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalnova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шальнова Светлана Анатольевна — доктор медицинских наук, профессор, руководитель отдела эпидемиологии хронических неинфекционных заболеваний.</p><p>От  имени  рабочей  группы.</p><p>SPIN-код: 9189-8637</p><p>Москва.</p></bio><bio xml:lang="en"><p>On behalf of the working group.</p><p>Moscow.</p></bio><email xlink:type="simple">SShalnova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр профилактической медицины Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>04</day><month>09</month><year>2019</year></pub-date><volume>18</volume><issue>4</issue><fpage>5</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Платонова Е.В., Деев А.Д., Горбунов В.М., Шальнова С.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Платонова Е.В., Деев А.Д., Горбунов В.М., Шальнова С.А.</copyright-holder><copyright-holder xml:lang="en">Platonova E.V., Deev A.D., Gorbunov V.M., Shalnova S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2290">https://cardiovascular.elpub.ru/jour/article/view/2290</self-uri><abstract><sec><title>Цель</title><p>Цель. Комплексно изучить самоконтроль  (СКАД)  и клиническое традиционное  измерение артериального  давления (ТАД) в оценке распространенности и маркеров фенотипов артериальной  гипертонии (АГ) в популяции лиц ≥55 лет.</p></sec><sec><title>Материал   и  методы</title><p>Материал   и  методы.   Из  проспективной  когорты  населения г. Москвы, случайным образом  сформирована выборка  (n=1871, 64% отклик), репрезентативная по параметрам  общего состояния здоровья,    образовательного    уровня,    времени    проживания в Москве, с равным количеством  мужчин и женщин. Сопоставив воспроизводимость  валидных  результатов  974  обследованных, результаты СКАД (4 сут.: 2 утром/2 вечером)  и ТАД (2 измерения) изучали совместно.  Оценивали распространенность фенотипов АГ у лиц без  антигипертензивной  терапии. Анализировали основные факторы  риска  и  предшествующий  анамнез  как потенциальные предикторы принадлежности к выявленному фенотипу. Результаты. На предварительном  этапе, средний возраст обследо­ ванных (n=1120) был 68,9±8 лет (43% мужчин; 44% с антигипертензивной   терапией).   Средний   уровень   СКАД   и   ТАД   составил 137,0±18,5/79,5±9,3 и 141,0±23,9/79,9±13,1 мм рт.ст., соответственно. Воспроизводимость показателей СКАД не уступала результатам ТАД (SD для систолического/диастолического АД (САД/ДАД) =18,5/9,3 vs 23,9/13,1  мм рт.ст., соответственно).  Среди 556 обследованных без лечения АГ (68,8±8 лет; 47% — мужчины; 42% — ТАД ≥140/90  мм рт.ст.;  39% — абдоминальное  ожирение;  17% — курение;  8% — сахарный диабет; 8% — инфаркт миокарда и 5% — мозговой инсульт в анамнезе), оба метода  выявили нормальный уровень АД у 42%, у 32% — стабильную АГ, у 10% — гипертонию белого халата (ГБХ) и у 16% — скрытую АГ. Наличие сахарного диабета и инфаркта миокарда в анамнезе  более чем в 1,5 раза повышало вероятность обнаружить скрытую АГ. Предикторами ГБХ были отсутствие абдоминального ожирения и мозговой инсульт в анамнезе.</p></sec><sec><title>Заключение</title><p>Заключение.  СКАД реклассифицировал данные о распространенности АГ в популяции. Совместное использование СКАД и ТАД позволило определить  каждого шестого обследованного  с амбулаторной АГ, не получавшего необходимое лечение. Низкая “чувствительность” СКАД в таком случае может “скрывать” стабильную АГ у каждого второго пациента с ГБХ и перенесенным ранее мозговым инсультом.</p></sec><sec><title>Рабочая группа</title><p>Рабочая группа: Александри А. Л., Баланова Ю. А., Капустина А. В., Константинов В. В.,  Кукушкин С. К., Лельчук И. Н., Муромцева Г. А., Тимофеева Т. Н., Худяков М. Б.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study a combined use of home (HBPM) and office (OBP) blood pressure  measurements in assessment of prevalence and predictors of hypertensive phenotypes  in population of 55 years and older.</p></sec><sec><title>Material and methods</title><p>Material and methods. From prospective cohort of Moscow population, a sample was randomly formed (n=1871, 64% response), representative of parameters of general health, educational level, time of residence in Moscow, and with an equal number of men and women. Data of HBPM (4 days: 2 morning/2 evening) and OBP (2 measurements) were studied in complex after comparing the reproducibility of the valid results in 974 subjects.  The prevalence  of hypertensive phenotypes  was assessed in subjects  without treatment.  The main risk factors and previous anamnesis were analyzed as potential predictors of belonging to the identified phenotype.</p></sec><sec><title>Results</title><p>Results. Preliminary results of 1120 patients are presented: mean age was 68,9±8 years, 43% of men; 44% with antihypertensive therapy. Themean   levels  of  HBPM and   OBP  were  137,0±18,5/79,5±9,3  and 141,0±23,9/  79,9±13,1 mmHg, respectively. The reproducibility of HBPM data was not inferior to OBP (SD for SBP/DBP =18,5/9,3  vs. 23,9/13,1 mmHg, respectively). Among 556 subjects  without treatment  (68,8±8 years; 47% — men; 42% — OBP ≥140/90  mmHg; 39% — abdominal obesity (AO); 17% — smoking; 8% — diabetes  mellitus (DM); 8% — history of myocardial infarction (MI) and 5% — history of stroke.  The both  methods  revealed  normal  level of  blood  pressure   in 42%  of patients, stable arterial hypertension — in 32%, white coat hypertension (WCH) — in 10%, masked  hypertension  (MH) — in 16%. DM and MI history increased  by more than 1,5 times the MH risk. History of stroke and AO absence were predictors of WCH.</p></sec><sec><title>Conclusion</title><p>Conclusion. HBPM reclassified data of arterial hypertension prevalence in the population. Combined use of HBPM and OBP allow to establish every sixth person  with ambulatory hypertension,  who requires antihypertensive treatment.  Low “sensitivity”  of HBPM in present  case “mask” stable arterial hypertension  in every second  patient with WCH and history of stroke.</p></sec><sec><title>Working group</title><p>Working group:   Alexandri A. L.,  Balanova Yu. A.,  Kapustina A. V., Konstantinov V. V.,   Kukushkin S. K.,  Lelchuk I. N.,  Muromtseva G. A., Timofeeva T. N., Khudyakov M. B.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>распространенность артериальной  гипертонии</kwd><kwd>самоконтроль артериального  давления</kwd><kwd>гипертония белого халата</kwd><kwd>скрытая артериальная  гипертония</kwd></kwd-group><kwd-group xml:lang="en"><kwd>prevalence  of arterial hypertension</kwd><kwd>home blood pressure measurements</kwd><kwd>white coat hypertension</kwd><kwd>masked hypertension</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Коллектив авторов  выражает  искреннюю благодарность рабочей группе</funding-statement><funding-statement xml:lang="en">The  team  of  authors   gratefully  acknowledge working group</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">1999 World Health Organization — International Society of Hypertension Guidelines for the Management of Hypertension, Guidelines sub-committee of the World Organization, Clinical and Experimental Hypertension, 21:5-6:1009-60. doi:10.3109/10641969909061028.</mixed-citation><mixed-citation xml:lang="en">1999 World Health Organization — International Society of Hypertension Guidelines for the Management of Hypertension, Guidelines sub-committee of the World Organization, Clinical and Experimental Hypertension, 21:5-6:1009-60. doi:10.3109/10641969909061028.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-48. doi:10.1097/01.hjh.0000059016.82022.ca.</mixed-citation><mixed-citation xml:lang="en">O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-48. doi:10.1097/01.hjh.0000059016.82022.ca.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESHGuidelines for themanagement ofarterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESHGuidelines for themanagement ofarterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hyperten. 2007;25:2193-8. doi:10.1097/HJH.0b013e3282ef6185.</mixed-citation><mixed-citation xml:lang="en">Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hyperten. 2007;25:2193-8. doi:10.1097/HJH.0b013e3282ef6185.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stergio Home blood pressure normalcy: The Didima study. Am J Hypertens. 2000;13(6):678-85. doi:10.1016/S0895-7061(99)00266-6.</mixed-citation><mixed-citation xml:lang="en">Stergio Home blood pressure normalcy: The Didima study. Am J Hypertens. 2000;13(6):678-85. doi:10.1016/S0895-7061(99)00266-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. Japan. J Hypertens. 1998;16:971-5. doi:10.1097/00004872-199816070-00010.</mixed-citation><mixed-citation xml:lang="en">Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. Japan. J Hypertens. 1998;16:971-5. doi:10.1097/00004872-199816070-00010.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-83. doi:10.1161/01.CIR.0000160923.04524.5B.</mixed-citation><mixed-citation xml:lang="en">Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-83. doi:10.1161/01.CIR.0000160923.04524.5B.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">G, G,R, European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505-30. doi:10.1097/HJH.0b013e328308da66.</mixed-citation><mixed-citation xml:lang="en">G, G,R, European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505-30. doi:10.1097/HJH.0b013e328308da66.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR).BMC Public Health. 2009;9:293. doi:10.1186/1471-2458-9-293.</mixed-citation><mixed-citation xml:lang="en">Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR).BMC Public Health. 2009;9:293. doi:10.1186/1471-2458-9-293.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Баланова Ю.А, Шальнова С. А., Деев А. Д. и др. Динамика артериальной гипертонии и ее влияние на смертность в российской популяции. Системные гипертензии. 2014;4:17-21.</mixed-citation><mixed-citation xml:lang="en">Balanova JuA, Shal'nova SA, Deev AD, et al. Dynamics of arterial hypertension and its impact on mortality in Russian population. Sistemnye gipertenzii. 2014;4:17-21. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">SAS User's Guide: Statistics Version, 5 Edition. Cary NC: SAS Institute Inc. 1985. 956 pp.</mixed-citation><mixed-citation xml:lang="en">SAS User's Guide: Statistics Version, 5 Edition. Cary NC: SAS Institute Inc. 1985. 956 pp.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sega R, Trocino G, Lanzarotti A, et al. Alteration of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-92. doi:10.1161/hc3701.096100.</mixed-citation><mixed-citation xml:lang="en">Sega R, Trocino G, Lanzarotti A, et al. Alteration of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-92. doi:10.1161/hc3701.096100.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of „masked" hypertension and “white-coat„ hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. JACC. 2005;3:508-15. doi:10.1016/j.jacc.2005.03.070.</mixed-citation><mixed-citation xml:lang="en">Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of „masked" hypertension and “white-coat„ hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. JACC. 2005;3:508-15. doi:10.1016/j.jacc.2005.03.070.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ritter AM V, Faria AP De, Modolo R. White coat syndrome and its variations : differences and clinical impact. Integred Blood Pressure Control. 2018;73-9. doi:10.2147/IBPC.S152761.</mixed-citation><mixed-citation xml:lang="en">Ritter AM V, Faria AP De, Modolo R. White coat syndrome and its variations : differences and clinical impact. Integred Blood Pressure Control. 2018;73-9. doi:10.2147/IBPC.S152761.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mallion J, Ormezzano O, Barone-Rochette G, et al. Hypertension arterielle masquee: myrhe ou realite. Presse Med. 2008;37:1034-7. doi:10.1016/j.lpm.2008.01.022.</mixed-citation><mixed-citation xml:lang="en">Mallion J, Ormezzano O, Barone-Rochette G, et al. Hypertension arterielle masquee: myrhe ou realite. Presse Med. 2008;37:1034-7. doi:10.1016/j.lpm.2008.01.022.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Franklin SS, O'Brien E, Staessen JA. Masked hypertension: Understanding its complexity. Eur Heart J. 2017;38(15):1112-8. doi:10.1093/eurheartj/ehw502.</mixed-citation><mixed-citation xml:lang="en">Franklin SS, O'Brien E, Staessen JA. Masked hypertension: Understanding its complexity. Eur Heart J. 2017;38(15):1112-8. doi:10.1093/eurheartj/ehw502.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Parati G, Stergiou G. Self blood pressure measurement at home: how many times? J Hypertens. 2004;22:1075-9. doi:10.1097/01.hjh.0000125433.28861.55.</mixed-citation><mixed-citation xml:lang="en">Parati G, Stergiou G. Self blood pressure measurement at home: how many times? J Hypertens. 2004;22:1075-9. doi:10.1097/01.hjh.0000125433.28861.55.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Brguljan-Hitij J, Thijs L, Li Y, et al. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014;27:956-65. doi:10.1093/ajh/hpu002. Nesbitt SD, Amerena JV, Grant E, et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh study. Am J Hypertens. 1997;10:1270-80. PMID: 9397247.</mixed-citation><mixed-citation xml:lang="en">Brguljan-Hitij J, Thijs L, Li Y, et al. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014;27:956-65. doi:10.1093/ajh/hpu002. Nesbitt SD, Amerena JV, Grant E, et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh study. Am J Hypertens. 1997;10:1270-80. PMID: 9397247.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hozawa A, Ohkubo T, Kikuya M. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res. 2002;1:57-63. doi:10.1291/hypres.25.57.</mixed-citation><mixed-citation xml:lang="en">Hozawa A, Ohkubo T, Kikuya M. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res. 2002;1:57-63. doi:10.1291/hypres.25.57.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Muntner P, Shimbo D, Chair V, et al. Measurement of Blood Pressure in Humans A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35-66. doi:10.1161/HYP.0000000000000087.</mixed-citation><mixed-citation xml:lang="en">Muntner P, Shimbo D, Chair V, et al. Measurement of Blood Pressure in Humans A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35-66. doi:10.1161/HYP.0000000000000087.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
